Literature DB >> 27091658

[Application and interpretation of the R classification for lung cancer : Results of a survey of certified lung cancer centers].

H Hoffmann1, K Junker2, C Kugler3, P A Schnabel4, A Warth5.   

Abstract

The residual (R) tumor classification is an essential, even if facultative component of the TNM classification; however, it should alway be included in the pathology results of certified lung cancer centers. In discussions it becomes clear again and again that different hospitals and departments have different approaches and interpretations with respect to the R status after lung resection. We carried out a questionnaire-based survey of pathologists (with specialization in pulmonary pathology) and thoracic surgeons on the application of the R classification for lung tumors. The results of the survey revealed the different perceptions of the participating centers with respect to application and interpretation, which results in divergent decisions for adjuvant therapy and complicates the comparability of national and international studies. The results of the survey are especially valuable because all participants have a high level of expertise in the field of thoracic pathology and the data reflect the current practice in certified lung cancer centers. It appears to be necessary to examine the application and interpretation of the R classification for lung cancer more closely in an interdisciplinary exchange and to produce a catalogue of criteria to guarantee at least a better national standardization.

Entities:  

Keywords:  Application; Interdisciplinary exchange; Interpretation; Standardization; TNM classification

Mesh:

Year:  2016        PMID: 27091658     DOI: 10.1007/s00292-016-0141-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  19 in total

1.  Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis.

Authors:  Marc Riquet; Karima Achour; Christophe Foucault; Françoise Le Pimpec Barthes; Antoine Dujon; Aurélie Cazes
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

2.  [Residual tumor classification in oncology -- applications and problems].

Authors:  Christian Wittekind
Journal:  Zentralbl Chir       Date:  2009-02-23       Impact factor: 0.942

3.  [Prevention, diagnosis, therapy, and follow-up of lung cancer].

Authors:  G Goeckenjan; H Sitter; M Thomas; D Branscheid; M Flentje; F Griesinger; N Niederle; M Stuschke; T Blum; K-M Deppermann; J H Ficker; L Freitag; A S Lübbe; T Reinhold; E Späth-Schwalbe; D Ukena; M Wickert; M Wolf; S Andreas; T Auberger; R P Baum; B Baysal; J Beuth; H Bickeböller; A Böcking; R M Bohle; I Brüske; O Burghuber; N Dickgreber; S Diederich; H Dienemann; W Eberhardt; S Eggeling; T Fink; B Fischer; M Franke; G Friedel; T Gauler; S Gütz; H Hautmann; A Hellmann; D Hellwig; F Herth; C P Heussel; W Hilbe; F Hoffmeyer; M Horneber; R M Huber; J Hübner; H-U Kauczor; K Kirchbacher; D Kirsten; T Kraus; S M Lang; U Martens; A Mohn-Staudner; K-M Müller; J Müller-Nordhorn; D Nowak; U Ochmann; B Passlick; I Petersen; R Pirker; B Pokrajac; M Reck; S Riha; C Rübe; A Schmittel; N Schönfeld; W Schütte; M Serke; G Stamatis; M Steingräber; M Steins; E Stoelben; L Swoboda; H Teschler; H W Tessen; M Weber; A Werner; H-E Wichmann; E Irlinger Wimmer; C Witt; H Worth
Journal:  Pneumologie       Date:  2010-03-09

4.  Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery.

Authors:  Jacquelyn G Hancock; Joshua E Rosen; Alberto Antonicelli; Amy Moreno; Anthony W Kim; Frank C Detterbeck; Daniel J Boffa
Journal:  Ann Thorac Surg       Date:  2014-12-17       Impact factor: 4.330

Review 5.  "Incomplete resection" in non-small cell lung cancer: need for a new definition. Canadian Lung Oncology Group.

Authors:  Y Lacasse; H C Bucher; E Wong; L Griffith; S Walter; R J Ginsberg; G H Guyatt
Journal:  Ann Thorac Surg       Date:  1998-01       Impact factor: 4.330

6.  [Incomplete resections in bronchial carcinoma: morbidity and prognosis].

Authors:  H Dienemann; C Trainer; H Hoffmann; H Bülzebruck; T Muley; K Kayser; I Vogt-Moykopf
Journal:  Chirurg       Date:  1997-10       Impact factor: 0.955

7.  TNM residual tumor classification revisited.

Authors:  Christian Wittekind; Carolyn C Compton; Frederick L Greene; Leslie H Sobin
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

8.  Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer.

Authors:  B Passlick; I Sitar; W Sienel; O Thetter; A Morresi-Hauf
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

9.  A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.

Authors:  Christian Wittekind; Carolyn Compton; Phil Quirke; Iris Nagtegaal; Susanne Merkel; Paul Hermanek; Leslie H Sobin
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

10.  Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

Authors:  George Rodrigues; Hak Choy; Jeffrey Bradley; Kenneth E Rosenzweig; Jeffrey Bogart; Walter J Curran; Elizabeth Gore; Corey Langer; Alexander V Louie; Stephen Lutz; Mitchell Machtay; Varun Puri; Maria Werner-Wasik; Gregory M M Videtic
Journal:  Pract Radiat Oncol       Date:  2015 May-Jun
View more
  1 in total

1.  cR and pR: The Residual Tumor Classification Revisited.

Authors:  Arne Warth
Journal:  Pathol Oncol Res       Date:  2017-04-21       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.